"When these data were presented, there was an electrifying atmosphere in the hall. This was simply terrific," said Clara Lehmann, who heads the German Center for Infection Research (DZIF) at the University Hospital of Cologne.
Lenacapavir, an antiretroviral drug, is said to be almost 100% effective in the prevention and treatment of HIV infections, requiring only two injections per year.
Astrid Berner-Rodoreda highlighted that lenacapavir's biannual injection can be a significant relief for individuals facing stigmatization or care constraints.
Lenacapavir functions as a capsid inhibitor, disrupting the function of a vital protein of the virus, which prevents its replication.
Collection
[
|
...
]